Cargando…
Mutations in Isocitrate Dehydrogenase 1 and 2 Occur Frequently in Intrahepatic Cholangiocarcinomas and Share Hypermethylation Targets with Glioblastomas
Mutations in the genes encoding isocitrate dehydrogenase, IDH1 and IDH2, have been reported in gliomas, myeloid leukemias, chondrosarcomas, and thyroid cancer. We discovered IDH1 and IDH2 mutations in 34 of 326 (10%) intrahepatic cholangiocarcinomas. Tumor with mutations in IDH1 or IDH2 had lower 5-...
Autores principales: | Wang, Pu, Dong, Qiongzhu, Zhang, Chong, Kuan, Pei-Fen, Liu, Yufeng, Jeck, William R., Andersen, Jesper B., Jiang, Wenqing, Savich, Gleb L., Tan, Ting-Xu, Auman, J. Todd, Hoskins, Janelle M., Misher, Anne D., Moser, Catherine D., Yourstone, Scott M., Kim, Jin Woo, Cibulskis, Kristian, Getz, Gad, Hunt, Heike V., Thorgeirsson, Snorri S., Roberts, Lewis R., Ye, Dan, Guan, Kun-Liang, Xiong, Yue, Qin, Lun-Xiu, Chiang, Derek Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500578/ https://www.ncbi.nlm.nih.gov/pubmed/22824796 http://dx.doi.org/10.1038/onc.2012.315 |
Ejemplares similares
-
Isocitrate dehydrogenase 1 mutation sensitizes intrahepatic cholangiocarcinoma to the BET inhibitor JQ1
por: Fujiwara, Hiroaki, et al.
Publicado: (2018) -
Loss of BAP1 Expression Occurs Frequently in Intrahepatic Cholangiocarcinoma
por: Andrici, Juliana, et al.
Publicado: (2016) -
Mutation of Isocitrate Dehydrogenase 1 in Cholangiocarcinoma Impairs Tumor Progression by Inhibiting Isocitrate Metabolism
por: Su, Li, et al.
Publicado: (2020) -
Intrahepatic cholangiocarcinomas with IDH1/2 mutation-associated hypermethylation at selective genes and their clinicopathological features
por: Lee, Kyoungbun, et al.
Publicado: (2020) -
Low expression and Hypermethylation of ATP2B1 in Intrahepatic Cholangiocarcinoma Correlated With Cold Tumor Microenvironment
por: Zhang, Xiehua, et al.
Publicado: (2022)